PPV and cataract surgery significantly improve VA

Article

Extensive pars plana vitrectomy and cataract extraction can significantly improve visual acuity in juvenile idiopathic arthritis patients suffering from severe ocular complications of uveitis.

Extensive pars plana vitrectomy (PPV) and cataract extraction can significantly improve visual acuity (VA) in juvenile idiopathic arthritis patients suffering from severe ocular complications of uveitis.

According to a study published in Ophthalmologica, instead of a complete lensectomy, 11 eyes of 7 patients underwent complete vitrectomy and peeling of the inner limiting membrane. Patients were included in the study if they had anteroposterior segment involvement, hypotony, inflammation control of less than 3 months, compliance issues, or rapidly progressive disease; phacoemulsification was allowed if the patient was more than 6 years old and had been inflammation-free for more than 3 months.

The researchers found that VA improved from a logMAR of 1.48 to 0.37 at 6 months and 0.20 at 12 months. No flare-up was observed within the first 6 months. Between 7 and 19 months 5 eyes developed inflammation, and at a median of 16 months glaucoma developed in 5 eyes. None of the patients in the study developed cystoid macular oedema.

To read an abstract of the study, click here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.